Etripamil | PDF
Nasal Spray for Stopping PSVT Seems Feasible, Safe in Long Term
HRS 2017: Could etripamil nasal spray be a “game-changer” for paroxysmal supraventricular tachycardia? - Cardiac Rhythm News
First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301) | Circulation: Arrhythmia and Electrophysiology
Positive Results from ReVeRA Phase 2 Study of Etripamil Nasal Spray in AFib-RVR Presented by Milestone Pharmaceuticals during AHA 2023 | DAIC
RAPID return to sinus rhythm after SVT using intranasal etripamil | Nature Reviews Cardiology
Etripamil Nasal Spray shows positive topline results in Paroxysmal Supraventricular Tachycardia
Nasal spray shows potential for quickly treating arrhythmia
NODE-301
Update on Etripamil Nasal Spray for the At-home Treatment of Acute Paroxysmal Supraventricular Tachycardia – touchCARDIO
Etripamil Nasal Spray Looks Promising for Self-Administered PSVT Treatment
Etripamil Nasal Spray For Acute Termination Of Spontaneous Episodes Of Paroxysmal Supraventricular Tachycardia. NODE-301 Trial
Etripamil Nasal Spray Shows Promising Phase III Results for PSVT Treatment - Xtalks
Milestone Pharmaceuticals' etripamil nasal spray meets primary endpoint of phase 3 trial in PSVT
Etripamil Nasal Spray in Paroxysmal SVT Speeds Conversion to Sinus Rhythm: RAPID | tctmd.com
NODE clinical trials of Etripamil nasal spray for PSVT - YouTube
Etripamil Nasal Spray Reduced ER Vistsis and More PSVT Resolution in New NODE-301 Analysis | DAIC
First Nasal Spray Successfully Treats Supraventricular Tachycardia | DAIC
Etripamil - Our Research & Dev - Milestone Pharma
Etripamil Nasal Spray Shows Promise for AF Patients With Rapid Ventricular Rate | tctmd.com
NODE-302 Data Supports Etripamil Nasal Spray for PSVT Resolution
PDF) Update on Etripamil Nasal Spray for the At-home Treatment of Acute Paroxysmal Supraventricular Tachycardia
Intranasal etripamil safe, effective for conversion of Paroxysmal supraventricular tachycardia to sinus rhythm
StudyPages - Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia
First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301) | Circulation: Arrhythmia and Electrophysiology
Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm | Journal of the American College of Cardiology
A Nasal Spray for Rapid Heartbeat Disorder Could Be Best Option for Self-Treatment, Study Shows
